Success Story: Robust Teledermetalogy Program Prepared Permanente for COVID-19 Telehealth Transformation | Dermatology | AMA STEPS Forward | AMA Ed Hub [Skip to Content]
[Skip to Content Landing]

Success Story: Robust Teledermetalogy Program Prepared Permanente for COVID-19 Telehealth Transformation

Based on an American Medical Association news article published June 12, 2020 and Mark Zarefsky's interview with Richard S. Isaacs, MD, CEO and executive director of The Permanente Medical Group and CEO of the Mid-Atlantic Permanent Medical Group, and co-CEO of the Permanente Federation.

Learn how a robust and well-oiled teledermatology program at The Permanente Medical Group (TPMG) facilitated an easy transition to organization-wide telehealth programming during the COVID-19 pandemic.

What Was the Problem?

The rapid appearance of the COVID-19 pandemic in the United States forced many physician practices into what—for them—was the unchartered world of telemedicine. Telehealth was a viable solution for many practices because it allowed them to leverage key technological tools to continue seeing patients, be it for a COVID-19 diagnosis or for a separate chronic condition.

For The Permanente Medical Group (TPMG) though, telemedicine is a technology that has been in place for more than 20 years. One aspect of the group's overall telehealth offerings is its teledermatology program, which has been in place in Northern California for nearly 15 years.

Developing the Intervention

The foundational teledermatology program

There has been a national shortage of dermatologists for decades. A 2016 article in JAMA reported that in the United States, there are fewer than 3.4 dermatologists for every 100 000 people.

Meanwhile, the US population continues to grow older. The US Census Bureau predicts that by 2030, 1 in every 5 Americans will be 65 or older and that by 2060, there will be more than 94 million Americans who are 65 or older, nearly twice as many as there are today.

“There's an aging population, and there's a lot of skin out there,” said Richard S. Isaacs, MD. “One in 5 people in the country develop skin cancer, but there is a plethora of benign skin conditions that also require the expertise of the dermatologist. So, you have increasing demand and a limited supply of dermatologists.”

It was that imbalance in supply and demand that led TMPG to launch a teledermatology program that is now one of the largest in the country, with more than 170 000 virtual interactions between dermatologists and patients in 2019. TPMG hosted more than 200 000 teledermatology video visits, and in early 2020, prior to the COVID-19 pandemic, 70% of dermatology visits in the system's Northern California locations were conducted using telehealth. In the past two months, during the pandemic, more than 95% of TPMG's dermatology visits have been virtual.

A basic example of how the TPMG teledermatology program works involves a patient who is concerned about a suspicious lesion or mole on their body. The patient can take a picture of the location in question and send it to their primary care physician for review. The physician can request the patient come in for a more thorough evaluation, or if the physician determines that a dermatologist should be involved, they can send the photo to an on-call dermatologist to review.

If the patient does an in-person evaluation, the physician can also take a higher-quality image and forward that to a dermatologist. The dermatologist can then decide whether there is a problem, if a prescription is needed, or if there should be an in-person evaluation and potential biopsy.

A study in the Journal of the American Academy of Dermatology in 2019 found that when TPMG dermatologists had the chance to look at well-photographed skin lesions, they were able to identify nearly 10% more cancers with almost 40% fewer referrals to the dermatology department.

Dr Isaacs said that even though patients who use the teledermatology program are remote, they still benefit from a personal connection with their dermatologist.

“There is a personal touch, it's just [through] a different vehicle,” he said. “It's a personalized experience. It's essentially a conversation with the physician, so it's just as personal.”

Translating teledermatology success into system-wide telehealth during COVID-19

While TPMG has adjusted to the rise of the coronavirus, the success of its teledermatology program provided useful guidance in how to care for patients who could not—or would not—leave their homes during stay-at-home orders.

“Teledermatology has taught us the value of driving performance with technology,” said Dr Isaacs. “We have dramatically ramped up our telehealth strategy and are maximizing our technology and integration in ways we haven't done before.”

About 80% of the outpatient care systemwide is now provided through video and telephone visits, Dr Isaacs said. In Northern California, TPMG is performing nearly as many video visits on average in one week than it conducted in all of 2019. Additionally, almost 60% of prescriptions are being filled through the system's mail-order pharmacy operations, compared with 32% prior to the pandemic.

Patients are given the option of how they want to connect with their doctor or other clinician—by video, phone, secure messaging, or in-person visit. However, the emphasis on telehealth has allowed TPMG to substantially reduce the number of patients entering its medical centers and offices and help mitigate the spread of the novel coronavirus.

Patient satisfaction, meanwhile, has not suffered.

“This approach has clearly driven patient convenience and effective care without delay across our program,” Dr Isaacs said. “And many of our patients who have not previously used our telehealth services have told us that they greatly appreciate the ease, convenience, and value of telehealth.”

Medicine's future got here faster

Dr Isaacs is not shy about his vision for what health care will look like in the coming years.

“We think [telehealth] is the future of healthcare delivery in this country,” he said. “If you need to connect to care, you should be able to have a virtual, on-demand session when and where you need it.”

TPMG has routinely shared its experience with teledermatology and other telehealth programs with the larger medical community in order to help others better understand how it is organized and how it can make the healthcare system more effective, affordable, and accessible.

“What we've learned from our telehealth program overall during the current COVID-19 pandemic is that the patients love this way of interacting with our physicians and clinicians because it provides timely access to care and the convenience of speaking with a physician from their own home,” Dr Isaacs said. “Telehealth demonstrates our patient-centered approach to care and our commitment to delivering high-quality care to our members and patients where and when they need it, and that doesn't have to be an in-person visit.”

Amid the ceaseless tragedy of the COVID-19 pandemic there's a small silver lining in the accelerated adoption of telemedicine, said Dr Isaacs.

“We're moving health care in the direction that we were trying to go,” he said, “but we're going there faster.”

AMA Steps Forward logo

AMA STEPS Forward™ presents actionable, practical toolkits and customizable resources that you can use to successfully implement meaningful and transformative change in your practice or organization. See How it Works

Article Information

Disclosure Statement: Unless noted, all individuals in control of content reported no relevant financial relationships.

Disclaimer: AMA STEPS Forward™ content is provided for informational purposes only, is believed to be current and accurate at the time of posting, and is not intended as, and should not be construed to be, legal, financial, medical, or consulting advice. Physicians and other users should seek competent legal, financial, medical, and consulting advice. AMA STEPS Forward™ content provides information on commercial products, processes, and services for informational purposes only. The AMA does not endorse or recommend any commercial products, processes, or services and mention of the same in AMA STEPS Forward™ content is not an endorsement or recommendation. The AMA hereby disclaims all express and implied warranties of any kind related to any third-party content or offering. The AMA expressly disclaims all liability for damages of any kind arising out of use, reference to, or reliance on AMA STEPS Forward™ content.

Close
Close
Close

Name Your Search

Save Search
Close
Close

Lookup An Activity

or

Close

My Saved Searches

You currently have no searches saved.

Close
Close